Researchers reported in Nature Communications that astrocyte mitochondrial shuttles can awaken dormant glioblastoma cells and help them evade immunity. Zhu, Wang, Wu and colleagues describe how quiescent tumor cells can transition into states that support immune escape, implying a physiological pathway rather than a purely tumor-intrinsic switch. The work centers on cellular metabolism and organelle trafficking as modulators of tumor state, highlighting mitochondria as an actionable node for controlling dormancy-to-activation transitions. In glioblastoma, where immune suppression and recurrence complicate treatment, understanding these transitions is critical. Mechanistic findings like these can shape target selection for combination therapies intended to disrupt tumor state switching while maintaining or restoring immune recognition.